MANCINI, ILARIA
MANCINI, ILARIA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Acquired Thrombotic Thrombocytopenic Purpura Occurring in Advanced Age : Impact of a Delayed Onset on Disease Expression
2019-07-01 P. Agosti, I. Mancini, S. Pontiggia, B. Ferrari, M. Biganzoli, A. Artoni, S.M. Trisolini, L. Facchini, C. Caria, F. Peyvandi
ADAMTS13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
2012-08-01 G. Bettoni, R. Palla, C. Valsecchi, D. Consonni, L.A. Lotta, S.M. Trisolini, I. Mancini, K.M. Musallam, F.R. Rosendaal, F. Peyvandi
ADAMTS13 activity, high VWF and FVIII levels in the pathogenesis of deep vein thrombosis
2021-01-01 M.T. Pagliari, M. Boscarino, A. Cairo, I. Mancini, I. Martinelli, P. Bucciarelli, F. Rossi, F.R. Rosendaal, F. Peyvandi
ADAMTS13-RELATED ASSAYS IN ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
2013-02-14 I. Mancini
ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura
2017-01-01 I. Mancini, B. Ferrari, C. Valsecchi, S. Pontiggia, M. Fornili, E. Biganzoli, F. Peyvandi
The ADAMTS13-von Willebrand factor axis in COVID-19 patients
2020-01-01 I. Mancini, L. Baronciani, A. Artoni, P. Colpani, M. Biganzoli, G. Cozzi, C. Novembrino, M. Boscolo Anzoletti, V. De Zan, M.T. Pagliari, R. Gualtierotti, S. Aliberti, M. Panigada, G. Grasselli, F. Blasi, F. Peyvandi
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
2018-10-01 E. Roose, G. Vidarsson, K. Kangro, O.J.H.M. Verhagen, I. Mancini, L. Desender, I. Pareyn, N. Vandeputte, A. Vandenbulcke, C. Vendramin, A. Schelpe, J. Voorberg, M. Azerad, L. Gilardin, M. Scully, D. Dierickx, H. Deckmyn, S.F. De Meyer, F. Peyvandi, K. Vanhoorelbeke
Case report : use of thienopyridines in a patient with acquired idiopathic thrombotic thrombocytopenic purpura
2012-10-01 L.A. Lotta, I. Mancini, G. Tuana, K.M. Musallam, F. Peyvandi
Congenital and acquired ADAMTS13 deficiency: two mechanisms, one patient
2015-01-01 B. Ferrari, A. Cairo, S. Pontiggia, I. Mancini, L. Masini, F. Peyvandi
Different clinical severity of first episodes and recurrence of thrombotic thrombocytopenic purpura
2010-12-01 L.A. Lotta, M.G. Mariani, D. Consonni, I. Mancini, R. Palla, A. Maino, D. Vucelic, M. Pizzuti, P.M. Mannucci, F. Peyvandi
Dramatic presentation of acquired thrombotic thrombocytopenic purpura associated with COVID-19
2020-10-01 M. Capecchi, C. Mocellin, C. Abbruzzese, I. Mancini, D. Prati, F. Peyvandi
Efficacy and Safety of Azathioprine during Remission of Immune-Mediated Thrombotic Thrombocytopenic Purpura
2021-11-01 C. Bichard, I. Mancini, P. Agosti, P. De Leo, A. Artoni, M. Capecchi, S.M. Trisolini, C. Fozza, F. Peyvandi
Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
2019-11-01 C. Valsecchi, M. Mirabet, I. Mancini, M. Biganzoli, L. Schiavone, S. Faraudo, D. Mane-Padros, D. Giles, J. Serra-Domenech, S. Blanch, S.M. Trisolini, L. Facchini, E. Rinaldi, F. Peyvandi
Factor V Leiden but not factor II 20210G>A is a risk factor in a large cohort of Iranian patients with premature coronary artery disease
2020-11-01 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
Factor V Leiden but Not Factor II 20210G>A Is a Risk Factor in a Large Cohort of Iranian Patients with Premature Coronary Artery Disease
2020-07-01 I. Mancini, S. Sadeghian, M.T. Pagliari, S.H. Abbasi, H. Poorhosseini, M.A. Boroumand, M. Lotfi-Tokaldany, E. Pappalardo, G. Colombo, F. Tafuri, P. Agosti, F.R. Rosendaal, F. Peyvandi
The features of acquired thrombotic thrombocytopenic purpura occurring at advanced age
2020-03-01 P. Agosti, I. Mancini, A. Artoni, B. Ferrari, S. Pontiggia, S.M. Trisolin, L. Facchini, F. Peyvandi
FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients
2014-08-01 I. Mancini, C. Valsecchi, L.A. Lotta, L. Deforche, S. Pontiggia, M. Bajetta, R. Palla, K. Vanhoorelbeke, F. Peyvandi
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
2018-12-06 A. Schelpe, E. Roose, B.S. Joly, I. Pareyn, I. Mancini, M. Biganzoli, H. Deckmyn, J. Voorberg, R. Fijnheer, F. Peyvandi, S.F. De Meyer, P. Coppo, A. Veyradier, K. Vanhoorelbeke
The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians
2020-10-21 I. Mancini, E. Giacomini, S. Pontiggia, A. Artoni, B. Ferrari, E. Pappalardo, R. Gualtierotti, S.M. Trisolini, S. Capria, L. Facchini, K. Codeluppi, E. Rinaldi, D. Pastore, S. Campus, C. Caria, A. Caddori, D. Nicolosi, G. Giuffrida, V. Agostini, U. Roncarati, C. Mannarella, A. Fragasso, G.M. Podda, S. Birocchi, A.M. Cerbone, A. Tufano, G. Menna, M. Pizzuti, M. Ronchi, A. De Fanti, S. Amarri, M. Defina, M. Bocchia, S. Cerù, S. Gattillo, F.R. Rosendaal, F. Peyvandi
Immunochip analysis identifies novel susceptibility loci in the human leukocyte antigen region for acquired thrombotic thrombocytopenic purpura
2016-01-01 I. Mancini, I. Ricano-Ponce, E. Pappalardo, A. Cairo, M.M. Gorski, G. Casoli, B. Ferrari, M. Alberti, D. Mikovic, M. Noris, C. Wijmenga, F. Peyvandi, E. Rinaldi, A. Melpignano, S. Campus, R.A. Podda, C. Caria, A. Caddori, E. Di Francesco, G. Giuffrida, V. Agostini, U. Roncarati, C. Mannarella, A. Fragasso, G.M. Podda, E. Bertinato, A.M. Cerbone, A. Tufano, G. Loffredo, V. Poggi, M. Pizzuti, G. Re, M. Ronchi, K. Codeluppi, L. Facchini, A. De Fanti, S. Amarri, S.M. Trisolini, S. Capria, L. Aprile, M. Defina, S. Ceru